Abstract
The current views on the role of androgendeficiency in development of age-dependent pathology, increase of death rate in men and the problem questions of testosterone replacement therapy are presented.
References
1. Hackett G., Kell P., Ralph D. et al. British Society for Sexual Medicine Guidelines on the Management of Erectile Dysfunction // J. Sex. Med. 2008, 5,1841-1846.
2. Araujo A.B., Durante R., Feldman H.A. et al. The relationship between depressive symptoms and male erectile dysfunction: cross sectional results from the MMAS // Psychosom. Med. 1998, 60, 458-465.
3. Mulligen T., Frick M.F., Zuraw Q.C. et al. Prevalence of hypogonadism in males aged at least 45 years: the HIM study // IJSP. 2006, 60, 762-769.
4. Khaw K.T., Dowsett M., Folkerd E. et al. Endogenous testosterone and mortality due to all causes cardiovascular disease аnd cancer in men: European Prospective Investigation into Cancer in Norfolk (EPIC-NORFOLK) prospective population study // Circulation. 2007, 16, 2694-2701.
5. Shores M.M., Matsumoto A.M., Sloan K.L. et al. Lоw serum testosterone and mortality in male veterans // Arch. Intern. Med. 2006, 166, 1660-1665.
6. Laughlin G.A., Barret-Connor E., Bergstrom J. Low serum testosterone and mortality in older men // J. Clin. Endocrinol. Metab. 2008, 93, 68-75.
7. Лучицький Є.В. Андрогендефіцитний стан у чоловіків, хворих на цукровий діабет 2 типу // Ендокринологія. 2012, 17, №. 2, 28-36.
8. Muller M., Grobbee D.E., den Tonkelaar I. et al. Endogenous sex hormones and metabolic syndrome in aging men // J. Clin. Endocrinol. Metab. 2005, 90, 2618-2623.
9. Gomula A. Late-onset hypogonadism – new point of view. Chapter 6. In: Sex Hormones. Ed. R.K. Dubey. Medan. 2012.
10. Tsai H.K., D’Amico A.V., Sadetsky N. et al. Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality // J. Natl. Cancer Inst. 2007, 99, 1516-1524.
11. Gray A., Feldman H.A., McKinlay J.B., Longcope C. Age and changing sex hormone levels in middle-aged men: results of the Massachusetts male aging study // J. Clin. Endocrinol. Metab. 1991, 73, 1016-1025.
12. E. Luchytskyy, V. Luchytskyy. Androgendeficiency in males with type 2 diabetes mellitus // J. Sex. Med. 2012, 4, N 2, 78.
13. Gomula A., Rabijewski M. Testosterone deficiency syndrome – diagnosis and treatment – based on age-related testosterone referent levels // Polish Sexol. 2010, 8, 1-16.
14. Zitzmann M., Faber S., Nieshlag E. Association of specific symptoms and metabolic risks with serum testosterone in older men // J.Clin.Endocrinol. Metab. 2006, 91, 4335-4343.
15. Lasarou S., Reyes-Vallejo L., Morgentaler A. Wide variability in laboratory reference values for serum testosterone // J. Sex. Med. 2006, 3, 1085-1089.
2. Araujo A.B., Durante R., Feldman H.A. et al. The relationship between depressive symptoms and male erectile dysfunction: cross sectional results from the MMAS // Psychosom. Med. 1998, 60, 458-465.
3. Mulligen T., Frick M.F., Zuraw Q.C. et al. Prevalence of hypogonadism in males aged at least 45 years: the HIM study // IJSP. 2006, 60, 762-769.
4. Khaw K.T., Dowsett M., Folkerd E. et al. Endogenous testosterone and mortality due to all causes cardiovascular disease аnd cancer in men: European Prospective Investigation into Cancer in Norfolk (EPIC-NORFOLK) prospective population study // Circulation. 2007, 16, 2694-2701.
5. Shores M.M., Matsumoto A.M., Sloan K.L. et al. Lоw serum testosterone and mortality in male veterans // Arch. Intern. Med. 2006, 166, 1660-1665.
6. Laughlin G.A., Barret-Connor E., Bergstrom J. Low serum testosterone and mortality in older men // J. Clin. Endocrinol. Metab. 2008, 93, 68-75.
7. Лучицький Є.В. Андрогендефіцитний стан у чоловіків, хворих на цукровий діабет 2 типу // Ендокринологія. 2012, 17, №. 2, 28-36.
8. Muller M., Grobbee D.E., den Tonkelaar I. et al. Endogenous sex hormones and metabolic syndrome in aging men // J. Clin. Endocrinol. Metab. 2005, 90, 2618-2623.
9. Gomula A. Late-onset hypogonadism – new point of view. Chapter 6. In: Sex Hormones. Ed. R.K. Dubey. Medan. 2012.
10. Tsai H.K., D’Amico A.V., Sadetsky N. et al. Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality // J. Natl. Cancer Inst. 2007, 99, 1516-1524.
11. Gray A., Feldman H.A., McKinlay J.B., Longcope C. Age and changing sex hormone levels in middle-aged men: results of the Massachusetts male aging study // J. Clin. Endocrinol. Metab. 1991, 73, 1016-1025.
12. E. Luchytskyy, V. Luchytskyy. Androgendeficiency in males with type 2 diabetes mellitus // J. Sex. Med. 2012, 4, N 2, 78.
13. Gomula A., Rabijewski M. Testosterone deficiency syndrome – diagnosis and treatment – based on age-related testosterone referent levels // Polish Sexol. 2010, 8, 1-16.
14. Zitzmann M., Faber S., Nieshlag E. Association of specific symptoms and metabolic risks with serum testosterone in older men // J.Clin.Endocrinol. Metab. 2006, 91, 4335-4343.
15. Lasarou S., Reyes-Vallejo L., Morgentaler A. Wide variability in laboratory reference values for serum testosterone // J. Sex. Med. 2006, 3, 1085-1089.
Downloads
Download data is not yet available.